FidoCure® GTM brain

category

market profile

• text: Veterinary oncology is adopting genomic profiling to inform treatment choices, but clinical evidence varies by biomarker and drug.
• text: FidoCure combines a veterinary clinical service with a canine cancer data platform for comparative oncology research.

personas

• title: Veterinary oncologist
  pains:

  • Standard treatment choices can be limited for an individual dog's tumor.
  • The clinician needs interpretable molecular findings and evidence before discussing targeted options.
• title: Veterinary specialty hospital medical director
  pains:

  • Offering advanced cancer diagnostics without building a molecular lab and pharmacy network in house.
  • Supporting clinicians and pet families with complex, case-specific decisions.
• title: Dog owner facing a cancer diagnosis
  pains:

  • Uncertainty about what options remain beyond standard therapy.
  • Balancing cost, side effects and quality of life with a veterinarian.

icp

• text: US veterinary oncology and specialty practices treating dogs with cancer and able to enroll patients through a veterinarian.
• text: Multi-site veterinary groups seeking to extend precision oncology access across clinics.

message pillars

• text: Personalize treatment using tumor genetics.
• text: Support veterinarians with clinical guidance.
• text: Enable access to oral targeted treatment.

objections

• objection: Will sequencing always identify a useful treatment?
  response: No. The company says not every patient will have results leading to targeted therapy; review case-specific evidence with the veterinarian.
• objection: How strong is the evidence and are drugs approved for dogs?
  response: Review tumor-specific evidence and extra-label treatment implications with the prescribing veterinarian; access to a human-approved drug does not establish canine efficacy.
• objection: What will testing and medication cost?
  response: Ask the veterinary practice for a current itemized quote and discuss monitoring and follow-up costs.

competitors

• name: Anivive Lifesciences
  why: SearchLight DNA is a competing canine tumor genomic panel.
• name: VetOmics
  why: Offers canine comprehensive genomic profiling and precision-treatment guidance.

influencers

• name: Christina Lopes
  url: https://fidocure.com/about-us/
  why: Co-founder and CEO speaking about canine precision medicine.
• name: Gerald Post
  url: https://fidocure.com/for-veterinarians/
  why: Veterinary oncology leader and company medical officer.

keywords

• canine tumor genomic testing
• veterinary precision oncology
• dog cancer DNA sequencing
• canine targeted cancer therapy
• veterinary molecular tumor profiling
• dog oncology treatment options

voice

• Science-led
• Compassionate toward pet families
• Collaborative with veterinarians

signals

• text: A specialty hospital is expanding oncology services or introducing genomic tumor profiling.
• text: A veterinarian is evaluating additional options for a canine patient after standard treatments.

pricing

motion

channels

• Veterinary partnerships
• Scientific publications
• Webinars
• Veterinary education
• SEO

confidence

Founders

• name: christina lopes
  title: Founder
  role: Founder